TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23322466

Group type: EXPERIMENTAL
Intervention: Tocilizumab-MTX 4 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tocilizumab-MTX 8 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo-MTX
Number of subjects: 0
Study: 21176903

Group type: EXPERIMENTAL
Intervention: Nurse-delivered care
Number of subjects: 701

Group type: COMPARATOR
Intervention: General practitioner care
Number of subjects: 701
Study: 19364000

Group type: EXPERIMENTAL
Intervention: morphine 0.1 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: morphine 0.2 mg
Number of subjects: 72

Group type: COMPARATOR
Intervention: saline (control group)
Number of subjects: 72
Study: 18361803

Group type: EXPERIMENTAL
Intervention: Combination of traditional chemotherapy drugs with agents that inhibit angiogenesis and EGF signaling pathways
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Agents that inhibit angiogenesis and EGF receptor alone or in combination
Number of subjects: 0
Study: 15238021

Group type: EXPERIMENTAL
Intervention: Manipulations of instructions to place importance on either the prospective memory task or the background task (Experiments 1 and 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulations of distinctiveness of prospective memory targets (Experiment 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation of the difficulty of prospective memory target encoding (Experiments 3 and 4)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative model evaluation
Number of subjects: 0
Study: 11230835

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 14644

Group type: COMPARATOR
Intervention: Eptifibatide or Tirofiban
Number of subjects: 14644
Study: 9272805

Group type: EXPERIMENTAL
Intervention: Attentionally demanding task performance in chronic pain patients with high pain intensity and high somatic awareness
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Chronic pain patients with high pain intensity and high somatic awareness
Number of subjects: 46
Study: 8154032

Group type: EXPERIMENTAL
Intervention: 1 rejection within the first year
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: > 1 rejection, the first episode in the first year
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: > or = 1 rejection, the first episode after the first year
Number of subjects: 653

Group type: COMPARATOR
Intervention: no rejection
Number of subjects: 653
Study: 3064599

Group type: EXPERIMENTAL
Intervention: Furosemide (50 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31229329

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide skin preparation
Number of subjects: 65
Study: 28930903

Group type: EXPERIMENTAL
Intervention: Localized cold therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no cold therapy)
Number of subjects: 0
Study: 25578927

Group type: EXPERIMENTAL
Intervention: 22 g freeze‐dried blueberry powder
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control powder
Number of subjects: 48
Study: 22775199

Group type: EXPERIMENTAL
Intervention: Insulin euglycaemic clamp
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Carbohydrate rich 'continental' breakfast
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Calorie reduced 'American' FDA breakfast
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Moxifloxacin without food
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Moxifloxacin with food
Number of subjects: 32
Study: 21790306

Group type: EXPERIMENTAL
Intervention: Transfusion with packed red blood cells to achieve high hemoglobin levels
Number of subjects: 1166

Group type: COMPARATOR
Intervention: No transfusion (Control)
Number of subjects: 1166
Study: 18492839

Group type: EXPERIMENTAL
Intervention: Prebiotic-supplemented hypoallergenic formula (8 g/L scGOS/lcFOS)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo-supplemented hypoallergenic formula (8 g/L maltodextrin)
Number of subjects: 152
Study: 17141703

Group type: EXPERIMENTAL
Intervention: Mid-level providers (manual vacuum aspiration)
Number of subjects: 2894

Group type: COMPARATOR
Intervention: Doctors (manual vacuum aspiration)
Number of subjects: 2894
Study: 12696978

Group type: EXPERIMENTAL
Intervention: Single-dose black currant anthocyanins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Black currant juice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anthocyanins
Number of subjects: 0
Study: 11020137

Group type: EXPERIMENTAL
Intervention: NuvaRing (etonogestrel 120 microg and ethinylestradiol 15 microg per day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: DSG/EE COC (desogestrel 150 microg/ethinylestradiol 30 microg)
Number of subjects: 16
Study: 9179516

Group type: EXPERIMENTAL
Intervention: Alprazolam (0.5 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 14
Study: 1489766

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior modification
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional education intervention (didactic lectures)
Number of subjects: 40
Study: 3516187

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg three times a day)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg three times a day)
Number of subjects: 18
Study: 29330204

Group type: EXPERIMENTAL
Intervention: Pazopanib (600 mg)
Number of subjects: 311
Study: 27578377

Group type: EXPERIMENTAL
Intervention: Titanium elastic nail system
Number of subjects: 34

Group type: COMPARATOR
Intervention: Stainless steel elastic nail system
Number of subjects: 34
Study: 24183206

Group type: EXPERIMENTAL
Intervention: Bottle-weaning intervention
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 24159785

Group type: EXPERIMENTAL
Intervention: Standard therapy plus thermoheliox (group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard method (group 2)
Number of subjects: 50
Study: 20697938

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Neixiyan (Ex-LE4), Waixiyan (Ex-LE5), Xuanzhong (GB39), and Taixi (KI3) for 30 min, once a day, for 2 courses with a 5-day interval in between.
Number of subjects: 245

Group type: COMPARATOR
Intervention: Intra-articular injection of 2 mL hyaluronic acid into the affected joint every 7 days for 5 times in total.
Number of subjects: 245
Study: 18787899

Group type: EXPERIMENTAL
Intervention: Tiotropium (18 microg once daily for 7 days)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (matched)
Number of subjects: 35
Study: 16169256

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 1000 mg/day to 3000 mg/day as adjunctive therapy
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 178
Study: 15124554

Group type: EXPERIMENTAL
Intervention: Partial breast irradiation (intraoperative radiotherapy, brachytherapy, or external radiotherapy using 3D conformal radiation therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole breast radiotherapy (50 Gy with an additional boost of 10 to 16 Gy)
Number of subjects: 0
Study: 10855594

Group type: EXPERIMENTAL
Intervention: HMO affiliation (Secure Horizons or First Seniority)
Number of subjects: 516
Study: 8852474

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 60
Study: 1387528

Group type: EXPERIMENTAL
Intervention: Surgery (bypass surgery)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty
Number of subjects: 263
Study: 6360774

Group type: EXPERIMENTAL
Intervention: Tripotassium dicitrato bismuthate (TDB)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 48
Study: 31060397

Group type: EXPERIMENTAL
Intervention: Cerebral placental ratio (CPR)
Number of subjects: 2852

Group type: EXPERIMENTAL
Intervention: Umbilical artery pulsatility index (UA PI)
Number of subjects: 2852

Group type: EXPERIMENTAL
Intervention: Renal artery pulsatility index (RA PI)
Number of subjects: 2852

Group type: EXPERIMENTAL
Intervention: Systolic diastolic ratio (RA SDR)
Number of subjects: 2852

Group type: EXPERIMENTAL
Intervention: Peak systolic velocity (RA PSV)
Number of subjects: 2852
Study: 30882479

Group type: EXPERIMENTAL
Intervention: Intervention group (intensivists who answered additional questions about patient prognosis)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (intensivists who did not answer additional questions about patient prognosis)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 116
Study: 27715348

Group type: EXPERIMENTAL
Intervention: Product B
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 43
Study: 26268496

Group type: EXPERIMENTAL
Intervention: Combined radical operation without breaking lower lip and mandible
Number of subjects: 365

Group type: COMPARATOR
Intervention: Standard operation (breaking lower lip and mandible)
Number of subjects: 365
Study: 24231837

Group type: EXPERIMENTAL
Intervention: Oxybutynin vaginal ring 4 mg daily
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Oxybutynin vaginal ring 6 mg daily
Number of subjects: 323

Group type: COMPARATOR
Intervention: Placebo vaginal ring
Number of subjects: 323
Study: 22541839

Group type: EXPERIMENTAL
Intervention: Cilostazol 100 mg
Number of subjects: 78
Study: 19958962

Group type: EXPERIMENTAL
Intervention: Intravenous allogeneic human mesenchymal stem cells (hMSCs)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 18173140

Group type: EXPERIMENTAL
Intervention: Kangyi Zhongyu Decoction (KZD)
Number of subjects: 75

Group type: COMPARATOR
Intervention: GnRH‐a
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: KZD + GnRH‐a
Number of subjects: 75
Study: 15293418

Group type: EXPERIMENTAL
Intervention: Single Bond (SB) at 5 s
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Single Bond (SB) at 15 s
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Single Bond (SB) at 30 s
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: One‐Step (OS) at 5 s
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: One‐Step (OS) at 15 s
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: One‐Step (OS) at 30 s
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Syntac Single Component (SSC) at 5 s
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Syntac Single Component (SSC) at 15 s
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Syntac Single Component (SSC) at 30 s
Number of subjects: 108
Study: 16264046

Group type: EXPERIMENTAL
Intervention: Self-management programme 'Living Well with COPD(TM)'
Number of subjects: 191

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 191
Study: 10613429

Group type: EXPERIMENTAL
Intervention: DHEA (50 mg capsules, two times daily for 12 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Androstenedione (50 mg capsules, two times daily for 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: DHEA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: DHEA and Androstenedione
Number of subjects: 40
Study: 8528478

Group type: EXPERIMENTAL
Intervention: Head optimally restrained
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Head minimally restrained
Number of subjects: 20

Group type: COMPARATOR
Intervention: Head optimally restrained and head minimally restrained
Number of subjects: 20
Study: 1902426

Group type: EXPERIMENTAL
Intervention: ponalrestat
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 7129293

Group type: EXPERIMENTAL
Intervention: Electrostimulation anesthesia (ESA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neurolept anesthesia (NLA)
Number of subjects: 0
Study: 31917835

Group type: EXPERIMENTAL
Intervention: Somapacitan 0.04 mg/kg/wk
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Somapacitan 0.08 mg/kg/wk
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Somapacitan 0.16 mg/kg/wk
Number of subjects: 59

Group type: COMPARATOR
Intervention: Daily GH 0.034 mg/kg/d
Number of subjects: 59
Study: 31449860

Group type: EXPERIMENTAL
Intervention: Sorafenib (Group B, 2013-2017)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Sorafenib (Group A, 2008-2012)
Number of subjects: 338
Study: 29352400

Group type: EXPERIMENTAL
Intervention: Date SMART intervention
Number of subjects: 109

Group type: COMPARATOR
Intervention: Knowledge‐only (KO) comparison group
Number of subjects: 109
Study: 26802160

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine (nab-P + Gem)
Number of subjects: 861

Group type: COMPARATOR
Intervention: gemcitabine alone (Gem)
Number of subjects: 861
Study: 24215801

Group type: EXPERIMENTAL
Intervention: 150% of baseline number of chews
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 200% of baseline number of chews
Number of subjects: 45

Group type: COMPARATOR
Intervention: 100% of baseline number of chews
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Increasing number of chews
Number of subjects: 45
Study: 22306585

Group type: EXPERIMENTAL
Intervention: Standard dose plus booster on day 21
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard dose
Number of subjects: 150
Study: 19161766

Group type: EXPERIMENTAL
Intervention: Rewarming to 37 degrees C (RW‐37 degrees)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Rewarming to 34 degrees C (RW‐34 degrees)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Sustained mild hypothermia at 34 degrees C (S‐34 degrees)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Normothermia (S‐37 degrees)
Number of subjects: 490
Study: 17206437

Group type: EXPERIMENTAL
Intervention: Moderate intensity plantar flexion exercise (3.44 +/- 0.73 W per unit active muscle mass)
Number of subjects: 9
Study: 16045528

Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system (LNG IUS)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Mefenamic acid
Number of subjects: 51
Study: 12195350

Group type: EXPERIMENTAL
Intervention: Highly active antiretroviral therapy (HAART)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Adjunctive therapeutic vaccine trial (for 11 of the 16 subjects)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Discontinued therapy
Number of subjects: 16
Study: 10774649

Group type: EXPERIMENTAL
Intervention: Permethrin-impregnated bed nets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo-treated bed nets
Number of subjects: 0
Study: 8563364

Group type: EXPERIMENTAL
Intervention: Computerized prompting system for test ordering
Number of subjects: 0
Study: 31157379

Group type: EXPERIMENTAL
Intervention: Combined (nutrition education and environmental dietary modification)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Environment (environmental dietary modification)
Number of subjects: 517
Study: 28522812

Group type: EXPERIMENTAL
Intervention: FELIAP (Factor ELeven Inhibitory APtamer)
Number of subjects: 89

Group type: COMPARATOR
Intervention: SCRAPT (scrambled aptamer control)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: FELIAP
Number of subjects: 89
Study: 25448332

Group type: EXPERIMENTAL
Intervention: Delafloxacin 300mg IV every 12h
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delafloxacin 450mg IV every 12h
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tigecycline 100mg IV×1, followed by 50mg IV every 12h
Number of subjects: 0
Study: 24153411

Group type: EXPERIMENTAL
Intervention: 4-week taper
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 2-week taper
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 1-week taper
Number of subjects: 70
Study: 20844459

Group type: EXPERIMENTAL
Intervention: Hib‐MenC‐TT booster
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: MenC‐CRM
Number of subjects: 271

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 271
Study: 18290565

Group type: EXPERIMENTAL
Intervention: Basiliximab induction therapy combined with Calcineurin inhibitors (CNI) and steroids
Number of subjects: 99

Group type: COMPARATOR
Intervention: Calcineurin inhibitors and steroids only (Control)
Number of subjects: 99
Study: 15613978

Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg
Number of subjects: 21

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 21
Study: 12453955

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 1079
Study: 10455633

Group type: EXPERIMENTAL
Intervention: Low-pressure inflatable mattress and cushion system (Repose)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Dynamic support mattress (Nimbus II) with alternating-pressure cushion (Alpha TranCell)
Number of subjects: 80
Study: 7739947

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg orally 1 hour before imaging procedure
Number of subjects: 85

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 85
Study: 2287655

Group type: EXPERIMENTAL
Intervention: Group cognitive therapy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Individual supportive treatment plus brief counseling contacts
Number of subjects: 10
Study: 7255511

Group type: EXPERIMENTAL
Intervention: Dextropropoxyphene/paracetamol (65 mg dextropropoxyphene hydrochloride and 650 mg paracetamol)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Enteric-coated aspirin (1.2 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Soluble aspirin (1.2 g)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31789000

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 162

Group type: COMPARATOR
Intervention: Dalteparin
Number of subjects: 162
Study: 30151994

Group type: EXPERIMENTAL
Intervention: V- AS group (vonoprazan 20-mg bid, amoxicillin 750-mg bid, sitafloxacin 100-mg bid for 7 days)
Number of subjects: 63

Group type: COMPARATOR
Intervention: PPI- AS group (esomeprazole 20-mg bid, rabeprazole 10-mg bid, or lansoprazole 30-mg bid; amoxicillin 750-mg bid; sitafloxacin 100-mg bid for 7 days)
Number of subjects: 63
Study: 24071772

Group type: EXPERIMENTAL
Intervention: GXR AM (Guanfacine Extended Release in the morning)
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: GXR PM (Guanfacine Extended Release in the evening)
Number of subjects: 461
Study: 26487300

Group type: EXPERIMENTAL
Intervention: Monthly survey plus tailored risk reduction messages
Number of subjects: 179

Group type: COMPARATOR
Intervention: Monthly internet survey alone
Number of subjects: 179

Group type: COMPARATOR
Intervention: Both intervention and control groups
Number of subjects: 179
Study: 23943412

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 22855581

Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Low IGF1R
Number of subjects: 79
Study: 19412914

Group type: EXPERIMENTAL
Intervention: 20G needle
Number of subjects: 200

Group type: COMPARATOR
Intervention: 22G needle
Number of subjects: 200
Study: 17537539

Group type: EXPERIMENTAL
Intervention: Low- to moderate-intensity, short-duration physical activity (12 min walking protocol)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Glucose preload (250 ml with water)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Whey protein preload (250 ml with water)
Number of subjects: 14

Group type: COMPARATOR
Intervention: SPLENDA Sucralose control (250 ml with water)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ventilation threshold (VeT)
Number of subjects: 14
Study: 15752236

Group type: EXPERIMENTAL
Intervention: Urinary albumin concentration (UAC) measured in a spot morning urine sample
Number of subjects: 2527

Group type: EXPERIMENTAL
Intervention: Albumin-creatinine ratio (ACR) measured in a spot morning urine sample
Number of subjects: 2527
Study: 12046341

Group type: EXPERIMENTAL
Intervention: 24-h ambulatory blood pressure monitoring
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: PTH assessment
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: BMI assessment
Number of subjects: 59
Study: 9651453

Group type: EXPERIMENTAL
Intervention: Room air
Number of subjects: 609

Group type: COMPARATOR
Intervention: 100% oxygen
Number of subjects: 609
Study: 7842816

Group type: EXPERIMENTAL
Intervention: rhDNase once daily
Number of subjects: 968

Group type: EXPERIMENTAL
Intervention: rhDNase twice daily
Number of subjects: 968

Group type: EXPERIMENTAL
Intervention: rhDNase
Number of subjects: 968

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 968
Study: 2153040

Group type: EXPERIMENTAL
Intervention: 50 IU of salmon calcitonin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 100 IU of salmon calcitonin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 200 IU of salmon calcitonin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 366722

Group type: EXPERIMENTAL
Intervention: benoxaprofen 200 mg b.d. for three weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: naproxen 250 mg b.d. for two weeks
Number of subjects: 0
Study: 30063267

Group type: EXPERIMENTAL
Intervention: High-functioning occasional heavy drinkers
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: High-functioning infrequent non-heavy drinkers
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Poor functioning frequent heavy drinkers
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Poor functioning infrequent heavy drinkers
Number of subjects: 806
Study: 29479872

Group type: EXPERIMENTAL
Intervention: Vitamin-D supplementation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Low vitamin-D levels
Number of subjects: 41